These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 26577528)

  • 1. PDL1 Regulation by p53 via miR-34.
    Cortez MA; Ivan C; Valdecanas D; Wang X; Peltier HJ; Ye Y; Araujo L; Carbone DP; Shilo K; Giri DK; Kelnar K; Martin D; Komaki R; Gomez DR; Krishnan S; Calin GA; Bader AG; Welsh JW
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26577528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo.
    Li J; Zhong X; Zhao Y; Shen J; Xiao Z; Pilapong C
    Sci Rep; 2024 Jan; 14(1):2348. PubMed ID: 38287075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircKRT1 drives tumor progression and immune evasion in oral squamous cell carcinoma by sponging miR-495-3p to regulate PDL1 expression.
    Yang Z; Chen W; Wang Y; Qin M; Ji Y
    Cell Biol Int; 2021 Jul; 45(7):1423-1435. PubMed ID: 33675276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
    Costa C; Indovina P; Mattioli E; Forte IM; Iannuzzi CA; Luzzi L; Bellan C; De Summa S; Bucci E; Di Marzo D; De Feo M; Mutti L; Pentimalli F; Giordano A
    Cell Death Dis; 2020 Sep; 11(9):748. PubMed ID: 32929059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma.
    Wang J; Zhao X; Wang Y; Ren F; Sun D; Yan Y; Kong X; Bu J; Liu M; Xu S
    Cell Death Dis; 2020 Jan; 11(1):32. PubMed ID: 31949130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
    Kang J; Kim E; Kim W; Seong KM; Youn H; Kim JW; Kim J; Youn B
    J Biol Chem; 2013 Sep; 288(38):27343-27357. PubMed ID: 23902763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.
    Kawami M; Takenaka S; Akai M; Yumoto R; Takano M
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platinum‑based chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death‑1 ligand 1 and HLA class I in non‑small cell lung cancer.
    Okita R; Maeda A; Shimizu K; Nojima Y; Saisho S; Nakata M
    Oncol Rep; 2019 Aug; 42(2):839-848. PubMed ID: 31173242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
    Ye M; Zhang J; Zhang J; Miao Q; Yao L; Zhang J
    Cancer Lett; 2015 Feb; 357(1):196-205. PubMed ID: 25444916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
    Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
    Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression and clinical outcome of small cell lung cancer.
    Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
    PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.
    Song C; Lu P; Sun G; Yang L; Wang Z; Wang Z
    Biochem Biophys Res Commun; 2017 Jan; 482(1):22-27. PubMed ID: 27836543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-34a suppresses the proliferation and invasion of gastric cancer by modulating PDL1 in the immune microenvironment.
    Yong H; Fu J; Gao G; Shi H; Zheng D; Zhou X
    Mol Cell Probes; 2020 Oct; 53():101601. PubMed ID: 32445780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary mechanisms of regulating PD‑L1 expression in non‑small cell lung cancer during the EMT process.
    Li F; Zhu T; Yue Y; Zhu X; Wang J; Liang L
    Oncol Rep; 2018 Aug; 40(2):775-782. PubMed ID: 29901173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
    Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
    Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of de novo expression of programmed cell death-ligand 1 in squamous cell carcinoma of the lung.
    Igarashi T; Teramoto K; Ishida M; Hanaoka J; Daigo Y
    Oncol Rep; 2017 Oct; 38(4):2189-2196. PubMed ID: 28791392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.